Moleculin Biotech's total assets for Q1 2025 were $21.01M, an increase of 24.15% from the previous quarter. MBRX total liabilities were $20.97M for the fiscal quarter, a 91.59% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.